MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41409-026-02870-9

Медицинская библиотека · Bone marrow transplantation · 2026

Prognostic factors and a novel scoring system for allogeneic hematopoietic stem cell transplantation in patients aged 70 years or older: a nationwide registry analysis in Japan.

Kataoka Asami, Yoshinaga Noriyoshi, Inoue Yoshitaka, Toubai Tomomi, Uchida Naoyuki, Ogura Kazuto, Uehara Yasufumi, Anzai Naoyuki, Wakayama Toshio, Wake Atsushi, Doki Noriko, Tokunaga Masahito, Eto Tetsuya, Hattori Norimichi, Tanaka Masatsugu, Watanabe Mitsumasa, Kamimura Tomohiko, Kawamura Koji, Fukuda Takahiro, Ohbiki Marie, Atsuta Yoshiko, Nakasone Hideki, Yakushijin Kimikazu, Kanda Junya

СтатьяПеревод в очереди

Аннотация

Despite recent advances, data on allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients aged ≥70 years remain limited. We identified prognostic factors and developed a risk score to guide transplant eligibility. Using the Japanese Transplant Registry Unified Management Program, we retrospectively analyzed 929 patients aged ≥70 years who underwent their first allo-HSCT for hematologic malignancies between 2000 and 2022. Prognostic factors were identified by multivariate Cox regression to construct a scoring system. The median patient age was 71 years (range, 70-88), with acute myeloid leukemia being the most common disease. The 2-year overall survival (OS) rate was 34.2%. Multivariate analysis identified age ≥75 years, ATL, lymphoma, high disease risk, hematopoietic cell transplant-specific comorbidity index ≥5, and performance status ≥2 as adverse factors. Using the hazard ratio-based scoring system derived from multivariate analysis, patients were stratified into low- (0), intermediate-1- (1), intermediate-2- (2-3), and high-risk (4-5) groups, with 2-year OS rates of 57.1%, 35.0%, 18.3%, and 2.5%, respectively (p < 0.01). We identified prognostic factors and developed a scoring system stratifying survival in patients aged ≥70 years, potentially facilitating the selection of older candidates most likely to benefit from allo-HSCT.

Для цитирования: Kataoka Asami, Yoshinaga Noriyoshi, Inoue Yoshitaka, Toubai Tomomi, Uchida Naoyuki, Ogura Kazuto, Uehara Yasufumi, Anzai Naoyuki, Wakayama Toshio, Wake Atsushi, Doki Noriko, Tokunaga Masahito, Eto Tetsuya, Hattori Norimichi, Tanaka Masatsugu, Watanabe Mitsumasa, Kamimura Tomohiko, Kawamura Koji, Fukuda Takahiro, Ohbiki Marie, Atsuta Yoshiko, Nakasone Hideki, Yakushijin Kimikazu, Kanda Junya. Prognostic factors and a novel scoring system for allogeneic hematopoietic stem cell transplantation in patients aged 70 years or older: a nationwide registry analysis in Japan.. Bone marrow transplantation. 2026. DOI: 10.1038/s41409-026-02870-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.